DiaMedica Therapeutics Inc. SEC filings DMAC
DiaMedica Therapeutics Inc. has 427 filings in SEC EDGAR's recent list, going back to May 16, 2007. Its latest annual report, Form ARS, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 10, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 11, 2026 | — |
| S-8 | Employee stock plan registration | Nov 13, 2025 | — |
| 424B2 | Prospectus | Aug 22, 2025 | — |
| S-3 | Shelf registration | Aug 12, 2025 | — |
| S-3 | Shelf registration | Aug 1, 2025 | — |
| 424B3 | Prospectus | Jul 18, 2024 | — |
| S-3 | Shelf registration | Jul 10, 2024 | — |
| S-8 | Employee stock plan registration | May 24, 2024 | — |
| S-3 | Shelf registration | Mar 21, 2024 | — |
| 424B3 | Prospectus | Jul 10, 2023 | — |
| S-3 | Shelf registration | Jun 30, 2023 | — |
| S-8 | Employee stock plan registration | Aug 11, 2022 | — |
| S-8 | Employee stock plan registration | Mar 14, 2022 | — |
| 424B3 | Prospectus | Oct 15, 2021 | — |
| S-3 | Shelf registration | Oct 5, 2021 | — |
| S-3 | Shelf registration | Mar 10, 2021 | — |
| 424B5 | Prospectus supplement | Aug 7, 2020 | — |
| 424B5 | Prospectus supplement | Aug 5, 2020 | — |
| 424B5 | Prospectus supplement | Feb 11, 2020 | — |
| 424B5 | Prospectus supplement | Feb 11, 2020 | — |
| S-3 | Shelf registration | Jan 2, 2020 | — |
| S-8 | Employee stock plan registration | May 23, 2019 | — |
| S-8 | Employee stock plan registration | Dec 14, 2018 | — |
| 424B4 | Prospectus | Dec 10, 2018 | — |
| S-1/A | Amended registration statement | Nov 28, 2018 | — |
| S-1/A | Amended registration statement | Nov 27, 2018 | — |
| S-1/A | Amended registration statement | Nov 19, 2018 | — |
| S-1 | Registration statement | Nov 9, 2018 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DMAC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Minneapolis, MN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1401040
- Former names
- DiaMedica Inc. (until Mar 11, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.